Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies
Journal: Current Opinion in Neurology; March 19, 2024
Author(s): Elisabeth Maillart, Kumaran Deiva, Romain Marignier
Clinical features of patients with MOGAD
This study is a review of previously published studies, aiming to summarize the clinical features of MOGAD. Over the last two decades, improvements in antibody testing methods have improved the accuracy of MOGAD diagnosis. Additionally, international criteria for MOGAD have been proposed for the first time. This study evaluates and explains each of the clinical features mentioned in the international criteria for MOGAD and also discusses potential challenges for the criteria to be applied in varied clinical settings. This study could be helpful for neurologists and patients looking to arrive at a treatment plan.
Related article: Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges
Free Access: Full text
